您的位置：
首页
>
农业专利
>
详情页
IMMUNE CHECKPOINT THERAPY
- 专利权人:
- KLEEF; Ralf
- 发明人:
- KLEEF, Ralf
- 申请号：
- SG11201907466Q
- 公开号：
- SG11201907466QA
- 申请日:
- 2018.02.28
- 申请国别(地区):
- SG
- 年份:
- 2019
- 代理人:
- 摘要：
- INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 07 September 2018 (07.09.2018) WIPO I PCT 0111111010 0111 °nolo OH mum oimIE (10) International Publication Number WO 2018/158314 Al (51) International Patent Classification: C07K 16/28 (2006.01) C07K 14/55 (2006.01) A61K 41/00 (2006.01) (21) International Application Number: PCT/EP2018/054925 (22) International Filing Date: 28 February 2018 (28.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 17158412.1 28 February 2017 (28.02.2017) EP (72) Inventor； and (71) Applicant: KLEEF, Ralf [AT/AT]； Auhofstrasse 1, 1130 Vienna (AT). (74) Agent: SONN & PARTNER PATENTANWALTE； Riemergasse 14, 1010 Vienna (AT). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, = (54) Title: IMMUNE CHECKPOINT THERAPY Fig. 1B Fig. 1C Fig. 1D Fig. 1E (57) : Disclosed is (a) an antibody or an antigen-binding portion thereof that specifically binds to and inhibits Programmed Death
- 来源网站：
- 中国工程科技知识中心
- 来源网址：
- http://www.ckcest.cn/home/
